Novozymes Falls as UBS Says Stock Overbought: Copenhagen Mover

Novozymes A/S, the world’s largest maker of industrial enzymes, fell the most in five weeks in Copenhagen after UBS AG said recent gains in the stock price imply unrealistic growth rates for the company’s main products.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.